Citations

Clear

879 citation(s) found for "Fernandez, G".

The dual role of leukotrienes in the tumor microenvironment: balancing pro-tumorigenic and anti-tumor immunity
Thake, Andrew , Caruso, Maria , Fernández-Bussy, Sebastián , Sacco, Keith , Sacco, Keith A

Mayo Clinic

Cancer Biology & Therapy | June 23, 2026 | Volume: 27 | Issue: 1 | Pages: No page available

10.1080/15384047.2026.2692168 | PMID 42335104 Get It

Implementation of Immersive Technologies in Pediatric Perioperative Care: A Multi-Institutional Survey Study
Handlogten, Kathryn S. , Fernandez, Allison, Li, Galaxy , Sadacharam, Kesavan

Mayo Clinic

Journal of Medical Extended Reality | June 23, 2026 | Volume: 3 | Issue: No issue available | Pages: No page available

10.1177/29941520261451587 | PMID 42558089 Get It

Background: Immersive technologies (ImTs), including virtual, augmented, or mixed reality, are increasingly used to support periprocedural pediatric patients, but clinical adoption varies widely across children’s hospitals and specialties. Multiple determinants for the adoption of ImT in health care have been identified; however, these have not been well characterized in pediatric perioperative settings. Aims: Among Society for Pediatric Anesthesia Improvement Network (SPAIN) member institutions, we describe the current state of pediatric perioperative ImT use, identify barriers and facilitators to ImT adoption, and report perceived implementation-related factors. Methods: We conducted a multi-institutional cross-sectional survey of pediatric perioperative practices via key contacts from SPAIN. Survey responses underwent mixed-methods analyses informed by the Consolidated Framework for Implementation Research. Results: Among 27 eligible institutions, 24 (89%) provided responses, 13 of which reported ImT use. Of these, 8 (62%) reported existing institutional infrastructure or governance to support ImT. Use patterns were highly heterogeneous, but use was commonly paired with the presence of champions, technology expertise, and available resource support. Use cases included anxiety reduction, distraction, and procedural support. Barriers, facilitators, and potential strategies for successful implementation were highlighted. Conclusions: ImT is used variably across pediatric anesthesia practices affiliated with SPAIN. These findings provide a descriptive snapshot of current practice and highlight factors commonly associated with adoption. Further work is needed to more rigorously characterize the implementation processes and evaluate strategies that may support integration of ImT into routine care in diverse clinical settings.
Extended Cancer Spectrum in Adults With Telomere Biology Disorders: Insights From a 113‐Patient Single‐Center Cohort
Franke, Madeline , Lasho, Terra L. , Finke, Christy M. , Simon, Rachel A, Ongie, Laura J., McCULLOUGH, K, Carmona, Eva M. , Simonetto, Douglas A., Mangaonkar, Abhishek A. , Ferrer, A, Patnaik, Mrinal M. , Franke, Madeline A , Mangaonkar, Abhishek A. , Patnaik, Mrinal , Carmona, Eva M , Lasho, Terra L , Fernandez, Jenna , Ongie, Laura , McCullough, Kristen , Simonetto, Douglas A. , Ferrer, Alejandro

Mayo Clinic

American Journal of Hematology | June 23, 2026 | Volume: 101 | Issue: 9 | Pages: 2469-2474

10.1002/ajh.70421 | PMID 42332385 Get It

Slow-wave sleep across the Alzheimer's disease continuum: cognitive trajectories and sex differences
Fernández‐Arcos, Ana, Mayà, Gerard, Hernández, Laura, Knezevic, Iva, Soldevila-Domenech, Natalia, Zetterberg, Henrik, Blennow, Kaj, Grinberg, Lea T, Muñoz-Lopetegi, Amaia, Martín‐Sobrino, Isabel, Arqueros, Aurora, GAIG, CARLES, Lladó, Albert, Val-Guardiola, Andrea, Iranzo, Álex, Study, Alfa, Tort‐Colet, Núria , Mayà, Gerard , Stankeviciute, Laura S , Minguillón, Carolina , Soldevila‐Domenech, Natalia , Sánchez‐Benavides, Gonzalo , Kassinopoulos, Michalis , Suárez‐Calvet, Marc , Holst, Sebastian C. , Zetterberg, Henrik , Blennow, Kaj , Grinberg, Lea T. , Muñoz‐Lopetegi, Amaia , Martín-Sobrino, Isabel , Montini, Angelica , Gaig, Carles , Lladó, Albert , Sánchez‐Valle, Raquel , Piñol‐Ripoll, Gerard , Val‐Guardiola, Andrea, Iranzo, Álex , Gispert, Juan Domingo , Molinuevo, José Luís , Falgàs, Neus , Grau‐Rivera, Oriol

Mayo Clinic

No container title available | June 18, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-9844198/v1 Get It

Abstract Background Sleep disturbances are common in Alzheimer's disease and have been reported in its preclinical stage. A detailed characterization of sleep disruption across the Alzheimer’s disease continuum is required to clarify its role as a potential therapeutic target and to evaluate the utility of sleep-related biomarkers. Methods Sleep architecture was characterized through detailed spectral and temporal analysis of the slow-wave activity using polysomnography across the Alzheimer’s disease continuum . Participants included: cognitively unimpaired individuals without abnormal Alzheimer’s disease biomarkers (n = 30), cognitively unimpaired individuals with abnormal Alzheimer’s disease biomarkers (n = 45), and individuals with mild cognitive impairment or mild dementia due to Alzheimer’s disease (n = 41). Associations between slow-wave features and longitudinal cognitive performance were tested in cognitively unimpaired participants. Sex differences were also explored. Results A stepwise increased wake after sleep onset and latency to rapid eye movement sleep was observed, alongside reduced spectral power of slow-wave activity and a progressive flattening of slow-waves across the Alzheimer’s disease continuum in both sexes. In cognitively unimpaired individuals, higher slow-wave slope and greater peak-to-peak amplitude were associated with better cognitive trajectories over time. Conclusions Sleep macro- and microarchitecture are altered early and progressively deteriorate across the Alzheimer’s disease continuum . Slow-wave features relate to cognitive trajectories in preclinical Alzheimer’s disease, with exploratory analyses suggesting stronger associations in men. These findings support slow-wave morphology as a candidate non-invasive marker for future sleep-based intervention studies.
Healthcare Education Pathway Pilot Programs May Advance Institutional Diversity Efforts
Elkhatib, Wiaam, Fernandez, Valerie, Alcindor, Sarah E., Boniface, Michael, Dinkins, Maryane, Ladlie, Beth, Ausejo, David, Austin, Andrew, Elkhatib, Wiaam Y , Elkhatib, Wiaam , Boniface, Michael , Dinkins, Maryane, Ladlie, Beth L., Austin, Andrew

Mayo Clinic

Journal of Allied Health | June 5, 2026 | Volume: 55 | Issue: 2 | Pages: 375-383

10.21091/jah.2026.02044 | PMID 42246748 Get It

Racial minorities remain underrepresented among allied health providers. Pathway programs address this gap by fostering career exposure and mentorship for underrepresented students. A pilot program was designed to increase underrepresented minority (URM) students entering health professions through career exploration and mentorship. High school students were enrolled into a pre-post survey study through a healthcare magnet school having higher proportions of economically disadvantaged students. Career exploration included healthcare presentations and skills sessions. Students were matched with mentors based on career interests. 22 students participated. The program facilitated career exploration sessions, mentor-mentee meetings, and workshops with diverse healthcare professionals. Participants reported increased likelihood towards pursuing healthcare careers. Preliminary findings suggest similar pilot pathway programs may increase URM student interest in healthcare careers.
EBUS ‐Guided Incidental Finding of Pulmonary Vein Thrombosis: A Case Report and Literature Review
Alqawasma, M, Yesilkaya, Y E, Rojas-Zapata, Tatiana A. , Murillo‐Torres, Regina, Lee-Mateus, A Yu, Vu, L, Fleissner, Zachary J., Husta, B C, Abia‐Trujillo, David , Fernandez-Bussy, S, Lee‐Mateus, Alejandra Yu , Vu, Linh H. , Alqawasma, Mohammed A., Yesilkaya, Yunus E, Yu Lee-Mateus, Alejandra , Vu, Linh H , Abia-Trujillo, David , Murillo‐Torres, Regina M.

Mayo Clinic

Respirology Case Reports | June 4, 2026 | Volume: 14 | Issue: 6 | Pages: No page available

10.1002/rcr2.70612 | PMID 42369328 Get It

ABSTRACT Pulmonary vein thrombosis (PVT) is an uncommon but potentially fatal condition that is often underdiagnosed due to nonspecific clinical presentation. We report a case of a 47‐year‐old woman with a thrombus in the right inferior pulmonary vein incidentally found during a robotic‐assisted bronchoscopy biopsy (RAB) and endobronchial ultrasound (EBUS) performed for mediastinal evaluation and lymph node sampling. PVT was confirmed with computed tomography pulmonary angiography, and the patient was successfully treated with anticoagulation therapy. A review of the literature revealed that reports of PVT detected via EBUS are exceedingly rare and usually malignant in nature. To our knowledge, this is the first peer‐reviewed case report describing PVT identified incidentally during EBUS, underscoring the potential of this technique to reveal clinically significant vascular abnormalities.
Mean Arterial Pressure at Admission Predicts 28-day Mortality in Patients With Severe Alcohol-Associated Hepatitis
Ventura-Cots, Meritxell, Clemente, Ana, Alvarado-Tapias, Edilmar, Ravi, Sujan, Cuyàs, Berta , Tanguy, M, Poca, Maria, Jäger, Marion , Arteel, Gavin E. , Villagrasa, Ares, Aguilar-Amorós, Anna, Argemí, Josepmaria , Abraldes, Juan G., Bosques, Francisco, Brown, R, Garcia-Taso, Guadalupe, Genesca, Juan, Schanbl, Bernd, Mathurin, P., Louvet, Alexander, Lucey, Michael R., Shawcross, Debbie L., Verna, Elisabeth, Dasarathy, S, Tu, Wanzhu, Kamath, Patrick S, Chalasani, Naga P, McClain, Craig J, Szabo, Gyongyi, Tang, Qing, Barton, Bruce, Nagy, Laura E. , Shah, Vijay H, Sanyal, Arun J, Singal, Ashwani K, Soriano, Germà, Rautou, Pierre Emmanuel, Shawcross, Debbie L. , Ventura Cots, Meritxell , Bataller, Ramon A , Shawcross, Debbie Lindsay , Cuyas, Berta , Ventura‐Cots, Meritxell , Alvarado‐Tápias, Edilmar , Ravi, Sujan, Tanguy, Marion , Poca, María , Fernández‐Carrillo, Carlos , Villagrasa, Ares , Abraldeṣ, Juan G. , Genescà, Joan , Mathurin, Philippe , Lucey, Michael R., Gawrieh, Samer , Tu, Wanzhu , Kamath, Patrick S. , Chalasani, Naga , McClain, Craig J. , Tang, Qing , Shah, Vijay H. , Sanyal, Arun J. , Mitchell, Mack , Singal, Ashwani K. , Rautou, Pierre-Emmanuel

Mayo Clinic

Clinical and Translational Gastroenterology | June 4, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.14309/ctg.0000000000001053 | PMID 42235929 Get It

INTRODUCTION: Alcohol-associated hepatitis (AH) is a severe condition with high short-term mortality. Identifying key predictors of poor outcomes is critical for guiding therapeutic strategies. Mean arterial pressure (MAP), a key determinant of tissue perfusion and systemic hemodynamics, may play a pivotal role in prognosis. METHODS: We analyzed a multicenter, prospective cohort of 323 patients hospitalized with AH, with validation in an independent cohort of 290 patients. Survival was evaluated using Kaplan-Meier curves and compared with the log-rank (Mantel-Cox) test. Cox proportional hazards models were used to estimate hazard ratios for mortality, adjusted for Model for end stage liver disease score. Mechanistic insights were explored through assessment of cardiovascular biomarkers. RESULTS: A baseline MAP <80 mm Hg was associated with significantly higher mortality at both 28 days (27.3% vs 8.0%) and 90 days (40.3% vs 15.6%; P < 0.001 for both). This association persisted after adjusting for Model for end stage liver disease score, age, and baseline hepatic encephalopathy. The incidence of infections during follow-up was similar across MAP groups (27.6% vs 22.8%), but acute kidney injury occurred more frequently in the MAP <80 mm Hg group (62% vs 38%, P < 0.001). In the validation cohort, patients with MAP <80 mm Hg also demonstrated significantly lower 28-day transplant-free survival. Although B-type natriuretic peptide and plasma renin levels were altered in patients with AH, they did not correlate with MAP values. DISCUSSION: A baseline MAP <80 mm Hg is an independent predictor of short-term and mid-term mortality in patients with AH. Strategies aimed at restoring hemodynamic stability may improve outcomes in this high-risk population.
Efficacy and safety outcomes of biweekly compared with standard triweekly gemcitabine/nab-paclitaxel in advanced pancreatic cancer: A systematic review and meta-analysis.
Castillo, Victor Andres, Salolin-Vargas, Vanessa Pamela, Padilla-Zambrano, Huber, Saldana, Mauricio Alejandro, Cerino-Peñaloza, Maria Susana, Fernandez, Wilfor Diaz , Maaliki, Liya, Ahmed, Abdallfatah, Luján, Mauricio , Vargas, Vanessa Pamela Salolin , Cerino-Peñaloza, María Susana

Mayo Clinic

Journal of Clinical Oncology | May 28, 2026 | Volume: 44 | Issue: 16_suppl | Pages: No page available

10.1200/jco.2026.44.16_suppl.e16405 Get It

e16405 Background: Pancreatic cancer remains one of the most lethal malignancies, with a rising incidence and persistently poor survival outcomes. Gemcitabine plus nab-paclitaxel is an established standard regimen for advanced disease, however, the conventional triweekly schedule is frequently associated with significant toxicity. Biweekly dosing has been proposed to enhance tolerability while maintaining efficacy, although evidence remains limited and heterogeneous. The objective was to evaluate the efficacy and safety of biweekly versus standard gemcitabine/nab-paclitaxel in patients with advanced pancreatic cancer. Methods: A systematic search of PubMed, Embase, and the Cochrane Library was conducted to identify studies comparing Biweekly versus Standard Triweekly: gemcitabine / nab-paclitaxel in patients with advanced pancreatic cancer. The primary outcomes of interest included partial response, and treatment-related toxicities, specifically anemia, neutropenia, and use of growth factors. Statistical analyses were performed using Review Manager. Heterogeneity was assessed using the I 2 statistic, and risk of bias was evaluated using the ROBINS-I tool. Results: A total of 1357 patients from eight observational studies were included. Comparative analysis showed no significant difference in partial response between biweekly and standard triweekly gemcitabine/nab-paclitaxel in patients with advanced pancreatic cancer with a risk ratio (RR) of 0.77 (95% CI 0.57,1.04, p = 0.09). Similarly, no significant differences were observed between regimens in the incidence of anemia (RR = 1.09; 95% CI 0.74–1.59; p = 0.66) or neutropenia (RR = 1.09; 95% CI 0.86–1.37; p = 0.48). however, growth factor use was significantly lower with biweekly dosing (RR = 0.71; 95% CI 0.58–0.87; p = 0.0009). Overall survival was comparable between groups RR = 1.02 (95% CI 0.71, 1.45 p = 0.93). Conclusions: Administration of gemcitabine/nab-paclitaxel biweekly yielded clinical outcomes and safety profiles comparable to the conventional regimen, while significantly reducing the need for growth factors as supportive care. These data suggest that a biweekly regimen could be an effective alternative; however, further prospective randomized studies are necessary to verify these findings and better understand their clinical application.